Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Sankyo Co., Ltd. engages in the manufacture and sale of pachinko and pachislot machines. It operates through the following segments: Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Others. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges and its related parts. The Pachislot Machines Business segment markets pachislot machines and related parts. The Ball Bearing Supply Systems segment sells pachinko and pachislot ball feeders, card system equipment, and parlor-related equipment. The Others segment comprises of mobile content service, real estate, golf club operations, and sells general molding products. The company was established on April 12, 1966 and is headquartered in Tokyo, Japan.

Sandoz AG, a subsidiary of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with the potential for efficacy and safety, while greatly reducing R&D risk, time, and expense.

The Baker Heart and Diabetes Institute, commonly known as the Baker Institute, is an Australian independent medical research institute headquartered in Melbourne, Victoria. Established in 1926, the institute is one of Australia's oldest medical research organisations with an historical focus on cardiovascular disease. In 2008, it became the country's first medical research institute to target diabetes, heart disease, obesity and their complications at the basic, clinical and population health levels.

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Daiichi Sankyo Healthcare Co., Ltd. engages manufacture and sale of pharmaceutical products. It produces and supplies over-the-counter drugs, quasi drugs, cosmetics, medical equipment, food, and beverages. The company was founded on December 16, 2005 and is headquartered in Tokyo, Japan.

Cal International is an online store for promotional items and offers promotional marketing, messaging and specialty advertising solutions.

Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Mimotopes Pty Ltd is an industry leader in the peptide and discovery chemistry sector. Mimotopes develops, markets and distributes high quality biochemical products and services for the life-science sector. Their customers range from small labs and universities worldwide, to large multinational drug discovery companies. Their core competence covers the following areas:\n' Custom Peptides\nMimotopes' custom peptides are synthesized in modern, automated synthesizers using advanced solid phase techniques. The value in using Mimotopes custom peptides is not only that they offer a wide range of peptide lengths, purities and quantities. Their customers can also draw on the exceptional experience of their technical staff, who consult with them to design the peptide application that gives the best possible research outcome.\n' PepSets Peptide Libraries\nPeptide libraries for various screening applications in Proteomics, Immunology and Drug Discovery. PepSets peptide libraries provide researchers with a rapid and cost effective solution for an immense range of bioactivity screening purposes. These sets of custom synthesized peptides enable fast, efficient results.\n' Peptide Reagents\nHigh-quality amino acids and peptide synthesis reagents. The same reagents that Mimotopes uses in its in-house production system.\n' SynPhase Lanterns\nModular solid phase supports for organic synthesis, combinatorial chemistry, peptide chemistry, molecule scavenging and affinity applications. Convenient to handle, SynPhase Lanterns are the unique and reliable alternative to using conventional resins for solid-phase synthetic chemistry. Not only do SynPhase Lanterns provide superior reaction kinetics, but their unrivalled ease of handling results in less errors, better traceability and ultimately, faster, more accurate results.

Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy.

Part of Pfizer Inc., Wyeth Lederle Japan Ltd is a company headquartered in Tokyo, Japan, specializing in pharmaceutical preparations. Wyeth Corp., now a subsidiary of Pfizer Inc. acquired Wyeth Lederle Japan Ltd from Takeda Pharmaceutical Co., Ltd. on May 21, 2003.

Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA.

Zibo Qidingli Patent Information Consulting Co., Ltd., established on 2013-06-03, Business scope includes patent technology consulting,to develop,to promote;advertisement plan(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**

Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland.